Better Access · Better Healthcare

At Abacus Medicine, we are innovative, dedicated, and we care.

We improve global healthcare through better access to medicine.

Abacus Medicine operates in multiple countries around Europe.
Find your local sales representatives and information here.

Five business people in meeting room in Abacus Medicine's headquarters in Copenhagen

Who is Abacus Medicine?

Abacus Medicine was founded in 2004 and has been growing fast ever since. We specialise in parallel import of medicine in Europe.

Blue and white truck ready to transport medicines around Europe

High-quality prescription medicine

Abacus Medicine supplies customers in multiple countries with more than 1,500,000 packs of prescription medicine each year. Like thousands of current customers, you will soon notice that we supply medicine at more affordable prices and with attractive sales conditions. The key is parallel import.

Who we help

We serve a wide range of customers across many European markets. Our expansive supplier network gives us the ability to supply parallel imported medicines at competitive prices while maintaining the highest quality standards. The result is significant savings for pharmacies, hospitals and pharmaceutical wholesalers.

Woman working in Abacus Medicine's warehouse in the Netherlands

Who we help

We serve a wide range of customers across many European markets. Our expansive supplier network gives us the ability to supply parallel imported medicines at competitive prices while maintaining the highest quality standards. The result is significant savings for pharmacies, hospitals and pharmaceutical wholesalers.

Be a part of Abacus Medicine Group

Join a young, ambitious and diverse company.
We are always looking for new and dedicated colleagues.

Latest reports from the Abacus Medicine Group

Front page of the Abacus Medicine Group's Annual Report 2021

Annual Report 2021

Numbers, earnings and more.
How did we progress and what are our plans?

Sustainability Report 2021

Employees, environment and more.
How did we progress and what are our plans?